Probiotics are microorganisms that are alive and typically consist of bacteria and yeast. When consumed in adequate amounts, probiotics can have a beneficial impact on an individual's health. Probiotics have shown potential for promoting animal and human health through various means [1]. In the European Union, prescribed microorganisms for animal use are predominantly gram-positive bacterial strains belonging to Bacillus, Enterococcus, Lactobacillus, Pediococcus, Streptococcus, and Saccharomyces cerevisiae as a yeast [2].
Meeting the growing demand for high-quality food and effectively controlling pathogenic microorganisms throughout the "farm-to-consumer" process has become a difficult task. This challenge arises due to transformations in animal production, food processing, and dietary habits, making an increasing number of consumers vulnerable to infection [3]. The use of probiotics can serve as a natural means to control and prevent the transmission of pathogens like Campylobacter, Escherichia coli, Clostridium, Yersinia enterocolitica, and Bacillus cereus throughout the food chain and different technologies [4].
L. plantarum is among the most popular probiotic bacteria utilized in animal feed. It helps to limit the growth of opportunistic pathogens in animal feed and intestines by reducing the pH value. Furthermore, it exhibits a wide-ranging inhibitory effect against different types of pathogens, including Listeria monocytogenes, Clostridium perfringens, Salmonella enterica, and E. coli [5].
Molecular cloning is a process that involves creating recombinant DNA molecules, transferring them into a host organism, and then cultivating them. Plasmids are tiny circular pieces of DNA that replicate within the host cell, independent of chromosomal or genomic DNA. Common plasmids used in recombinant DNA technology are typically optimized for studying and manipulating genes. For instance, most plasmids can be replicated in E. coli and are generally small in size (ranging from about 3000–6000 bp) to support easy manipulation. By forming phosphodiester bonds between the desired DNA and the plasmid vector, the desired DNA becomes part of a new recombinant plasmid [6].
Nisin is a small antimicrobial protein that is classified as a bacteriocin and originates from L. lactis. It also exhibits an antimicrobial effect against pathogens such as L. monocytogenes, which can cause severe illness and even fatalities in individuals such as the very young, elderly, pregnant, sick, and immunocompromised individuals. L. monocytogenes can thrive at low temperatures [7].
Nisin functions as a bacteriocin, exhibiting a broad-spectrum antimicrobial effect primarily against gram-positive bacteria found in food. However, current research suggests that the antimicrobial activity of nisin may be effective against a wide variety of non-food bacteria. Several studies have indicated that pure nisin, combined with other antibiotics, can show effectiveness against gram-negative pathogens, and bioengineered versions of nisin have been developed to enhance its activity against both gram-positive and gram-negative bacteria. Recently, researchers in interdisciplinary fields have explored new therapeutic applications of nisin for human diseases, leveraging its bioengineering potential. Nisin exhibits a dual mechanism for killing target cells: it inhibits cell wall synthesis and forms pores in it. In both mechanisms, nisin adheres to lipids, which are the primary transporter of the peptidoglycan structural units of bacterial cell walls, hindering their construction [8].
Nisin triggers the transcription of genes governed by nisA and nisF promoters via a two-component regulatory system [9], which encompasses NisK protein histidine kinase and NisR response regulator [10]. A transferable expression system with nisin control (NICE) has been developed [11] based on the combination of nisA promoter and nisRK regulatory genes [12]. This system consists of two compatible replicons, namely a regulatory plasmid bearing the nisRK regulatory genes and an expression vector containing the desired gene under the control of the nisA promoter. The system offers various benefits, including the ability to regulate the level of expression through the quantity of nisin employed for induction [12]; highly elevated levels of recombinant protein synthesis (up to 60% of all intracellular proteins) [13]; and undetectable expression of the target gene in the uninduced state, which permits the production of lethal proteins [14].
Improving the probiotic performance of L. plantarum as an additive in animal feed requires enhancing nutritional efficiency, increasing the absorption and digestion of food by farmed animals, and reducing bacterial pathogens in the human food chain. To boost the efficacy of this probiotic, nisin is required, which L. plantarum cannot produce and secrete on its own. Consequently, genetic engineering was employed to transfer the nisin gene from L. lactis to L. plantarum. For the first time, a specific primer of the nisin gene was designed, and the gene was purified using PCR before being transferred to the pET-21a(+) plasmid. The plasmid was then introduced into L. plantarum via electroporation (a process that involves applying electric pulses to cells to create temporary pores in their membranes) [15].